Different effect of percutaneous and surgical coronary revascularization on cardiac autonomic function and

Insights

Inflammation, indicated by C-reactive protein (CRP), correlates with cardiac autonomic dysfunction in chronic stable angina (CSA) patients with coronary artery disease (CAD). This association disappears after revascularization procedures like PCI or CABG.

Area of Science:

  • Cardiology
  • Clinical Research
  • Biomarkers

Background:

  • This study investigates the relationship between heart rate variability (HRV), a measure of cardiac autonomic function, and high-sensitivity C-reactive protein (CRP), a marker of inflammation, in patients with chronic stable angina (CSA).
  • The research included 77 CSA patients, categorizing them into obstructive coronary artery disease (CAD) and normal or near-normal coronary arteries (NCA) groups.
  • The impact of revascularization procedures, specifically percutaneous coronary interventions (PCI) and coronary artery bypass grafting (CABG), on HRV and CRP levels was evaluated six months post-intervention.

Discussion:

  • A significant inverse correlation was observed between CRP levels and HRV parameters in patients with CAD, suggesting that higher inflammation is linked to poorer autonomic function.
  • This correlation was not found in patients with NCA, indicating the association is specific to the presence of obstructive coronary artery disease.
  • Following PCI or CABG, the correlation between CRP and HRV was no longer significant, implying that revascularization alters this relationship.

Key Insights:

  • Cardiac autonomic dysfunction and inflammation are linked in patients suffering from coronary artery disease (CAD).
  • The inverse correlation between CRP and HRV in CAD patients highlights the interplay between inflammation and autonomic nervous system function in this population.
  • Revascularization procedures effectively diminish the association between inflammation and cardiac autonomic dysfunction.

Outlook:

  • Further research could explore the specific mechanisms by which revascularization impacts the inflammatory-autonomic axis in CAD patients.
  • Investigating long-term outcomes and the persistence of these changes post-intervention is warranted.
  • This study provides a foundation for understanding the complex pathophysiology of CAD and the benefits of revascularization beyond simple blood flow restoration.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...